Abstrak: Daun Sonchus arvensis L. telah digunakan secara tradisional untuk mengobati berbagai kondisi penyakit termasuk menurunkan tekanan darah dan meningkatkan urinasi. Penelitian ini dirancang untuk mengevaluasi potensi kardioprotektif ekstrak etanol daun Sonchus arvensis L. pada model hewan tikus infark miokardial yang diinduksi dengan isoproterenol. Tikus jantan jenis Wistar dibagi menjadi empat kelompok utama: kontrol negatif (hanya salin), kontrol positif (hanya isoproterenol), kelompok perlakuan ekstrak etanol daun Sonchus arvensis L. diberikan dalam tiga dosis yaitu 50, 100, dan 200 mg/kg bb p.o selama 14 hari. Pada hari ke 13 dan 14, isoproterenol (85 mg/kg bb) diberikan secara intraperitoneal pada kelompok kontrol positif dan ekstrak. Parameter yang diukur adalah enzim biomarker jantung, yaitu Creatine Kinase (CK), CK-MB, Aspartat Transaminase (AST), Alanine Transaminase (ALT) dan Laktat Dehidrogenase (LDH). Hasil penelitian menunjukkan bahwa ekstrak etanol daun Sonchus arvensis L. pada dosis 50 mg/kg bb secara signifi kan (P <0,05) menghambat peningkatan kadar CK, CK-MB, AST, ALT, dan LDH pada tikus yang mengalami serangan jantung miokardial dibandingkan dengan kontrol positif. Peningkatan dosis ekstrak S. arvensis tidak diikuti dengan peningkatan aktivitas kardioprotektif. Dengan demikian disimpulkan bahwa ekstrak daun Sonchus arvensis L. pada dosis 50 mg/kg bb memiliki potensi untuk dikembangkan sebagai obat kardioprotektif.
Plant Leaf Collection and Identification
Instruments. Sonchus arvensis L. leaves were collected from medicinal plants of PT. Kimia Farma, which is located at Baleendah street, Bandung, West Java. Determination of the plant was done at Herbarium Bandungense Bandung Institute of Technology.
Extraction of the Crude Plant. Preparation of ethanol extract of Sonchus arvencis L. leaves was done using cold extraction method. Five hundred gram of dried plant were inserted into macerator and soaked with 96% ethanol for 24 hours, liquid extract was then collected. Maceration process was repeated for 3 times. Furthermore, the liquid extract was concentrated using a rotating vacuum, and viscous extract was then dried in the oven at 50 ºC.
Experimental Animals. Male Wistar rats (150-200 g) were used for the experiment. All animals were obtained from the School of Pharmacy, Bandung Institute of Technology. The animals were acclimatized for 1 week at laboratory conditions before starting the experiment and fed with a standard pellet diet and water ad libitum. All animal experimental protocols have been approved by the Institutional Animal Ethics Committee (IAEC) in accordance with the Committee's guidelines for the Objective of Supervision and Control of Animal Experiments.
Experimental Design. The myocardial infarction was induced in experimental rats by intraperitoneal injection of isoproterenol hydrochloride (ISO) at a dose of 85 mg/kg body weight for 2 consecutive days.
The rats were randomly divided into fi ve groups with six rats each, as can be seen below:
• Group negative control: This group served as normal control and received normal saline (5 mL/kg b.w. i.p.).
• Group positive control (ISO): The rats were orally fed 0.9% normal saline once daily for 14 days and in addition received ISO (85mg/kg body weight i.p. ) on day 13 and 14 at an interval of 24 h.
• Group extract 50+ISO: The rats were pre-treated with ethanol extract of S. arvensis at dose of 50 mg/ kg b.w. p.o. for a period of 14 days and in addition received ISO (85 mg/kg body weight i.p.) on day 13 and 14 at an interval of 24 h.
• Group extract 100+ISO: The rats were pre-treated with ethanol extract of S. arvensis at dose of 100 mg/ kg b.w. p.o. for a period of 14 days and in addition received ISO (85mg/kg body weight i.p.) on day 13 and 14 at an interval of 24 h.
• Group extract 100+ISO: The rats were pre-treated with ethanol extract of S. arvensis at dose of 200 mg/ kg b.w. p.o. for a period of 14 days and in addition received ISO (85mg/kg body weight i.p. on day 13 and 14 at an interval of 24 h.
INTRODUCTION
BASED on World Health Organization, cardiovascular disease is the number one cause of deaths in the world (1) . Based on data in 2012 showed 17.5 million people died from cardiovascular disease. Among these, the ischemic heart diseases, acute myocardial infarction (MI) in particular, is one of the most alarming values.
The induction of myocardial infarction in isoproterenol-induced rats is a standard test in preclinical studies of cardioprotective eff ects that exhibit an infl uence on metabolic and morphological changes in cardiac tissue as in humans. Isoproterenol [1-(3, 4-dihydroxyphenyl) -2-isopropylamino ethanol hydrochloride] is a sympathomimetic group of drugs with an adrenegic beta-agonist mechanism in which it binds to the β1 receptor present in the heart that has the eff ect of increasing the contraction of the heart muscle (2) . Continuous contraction of the heart muscle can cause damage to the heart muscle cells. Isoproterenol induces necrosis in the sub-endocardial region of the left ventricle in the interventricular septum (3) . Myocardial infarction can be triggered by the presence of oxidative stress in which isoproterenol is a drug compound that can induce oxidative stress due to the presence of free radicals (4) . Sonchus arvensis L. leaves is a plant derived from Eurasia. It is known to have effi cacy as diuretic, anti-infl ammation and anti-pyretic. Sonchus arvensis L. contains fl avonoid in the form of luteolin, luteolin 7-O glucosida (5) , kaempferol, orientin, and quercetin (6) . A study showed that quercetin in plants have activity on cardiovascular disease, such as lowering blood pressure (7) . As quercetin has an activity as antioxidant, therefore, Sonchus arvensis L. was suspected to have cardioprotective activity. In this study, cardioprotective activity of Sonchus arvensis L. was conducted on isoproterenol-induced myocardial infarction in rats.
MATERIALS AND METHODS
MATERIALS. Isoproterenol was obtained from Sigma-Aldrich (MO, USA). Analyzing kits for measuring Creatine Kinase (CK), CK-MB, Aspartate Transaminase (AST), Alanine Transaminase (ALT) and Lactate Dehydrogenase (LDH) were obtained from Sclavo Diagnostic International, Italy. All of other reagents were analytical grades. All parameters were assessed using Microlab 300, ELITech Group, France.
After 24 h of the last treatment, orbital blood samples were collected from all groups. Serum samples were separated for the estimation of cardiac biomarkers such as Creatine Kinase (CK), CK-MB, Aspartate Transaminase (AST), Alanine Transaminase (ALT) and Lactate Dehydrogenase (LDH).
Statistical Analysis. Significant difference between control and experimental groups was assessed by ANOVA test. P<0.05 was considered to be statistically signifi cant.
RESULTS AND DISCUSSION
Myocardial infarction (MI) is a death or necrosis of myocardial tissue due to a sudden decrease of blood fl ow from coronary heart disease and or sudden increase of oxygen demand (8) . The present study showed development of oxidative cardiac injury induced by isoproterenol (9) which lead to signifi cant increase in cardiac biomarkers Creatine Kinase (CK), CK-MB, and Lactate Dehydrogenase (LDH) ( Table 1) . Creatinin kinase (CK) is an enzyme that is found in high concentrations in heart muscle and skeletal muscle damage. However, creatinine kinase is also present in the lungs, skeletal muscles, and the brain so it is not particularly specifi c to the heart muscle. Creatinine kinase is a dimeric molecule consisting of a pair of diff erent monomers namely MM, MB, and BB. While CK-MB is a heart muscle biomarker that increases in number if there is damage to the heart muscle (8) . Therefore, in myocardial infarction, CK level increase was followed by increasing of CK-MB level.
Lactate dehydrogenase (LDH) is an intracellular enzyme found in almost all metabolized cells. LDH with the highest concentration is found in the heart, skeletal muscle, liver, kidney, brain, and red blood cells. The increase of LDH level in serum suggests an increased of oxygen demand (10) . Other conditions that can cause increased LDH serum include hypoxia, tissue injury, and necrosis (11) (12) (13) . In this experimental results also showed a signifi cant increase in Aspartate Transaminase (AST) and Alanine Transaminase (ALT) level in the positive group compared to negative group (Table 1) . AST and ALT are specifi c transaminase enzymes present in liver cells, but also in the heart and brain. Although the serum AST and ALT are non-specifi c presence of heart, but its concentrations increased during MI.
In this study, it showed that administration of S. arvensis L. extract at doses of 50, 100 and 200 mg/ kg body weight could signifi cantly decrease level of CK (Fig.1) , CK-MB (Fig.2), LDH (Fig.3) , AST and ALT (Fig. 4) compared to isoproterenol-administration only. However, the dose increase did not affect reduction of those markers. It suggested that the extract eff ect did not dependent on the dose. infarction rats. ISO = rats were administered only with isoproterenol (85 mg/kg bw). Extract = rats were administered previously with S. arvensis extract at certain doses (50, 100, or 200 mg/kg bw) for 14 days before isoproterenol administration. * = signifi cantly diff erent limitation of this study is that the cardioprotective eff ect of S. arvensis extract was only determined by measuring the cardiac biomarker. It is important to do heart histopatology to observe its eff ect on preventing heart tissue damage due to isoproterenol administration. Moreover, this study was done on rat; it is unknown whether the results can be extrapolated to humans.
CONCLUSION
Sonchus arvensis L. extract ameliorates cardiotoxic eff ects of isoproterenol, therefore it has a potential to be developed as cardioprotective drug. isoproterenol-induced myocardial infarction rats. ISO =rats were administered only with isoproterenol (85 mg/kg bw). Extract + ISO = rats were administered previously with S. arvensis extract at certain doses (50, 100, or 200 mg/kg bw) for 14 days before isoproterenol administration. * = signifi cantly diff erent compared to ISO group (P<0.05).
Many studies have reported the role of plant medicine in inhibiting the cardiotoxic effect of isoproterenol (14) (15) (16) described that pretreatment with Punica granatum extract can reduce the cardiotoxic biomarker and has a lesser degree of cellular infi ltration. Yousefi et al. stated the antioxidant activity might play a role in cardioprotective eff ect (15) . As S. arvensis extract has an antioxidant activity (6) , therefore it can explain its cardioprotective eff ect.
This study implies a pharmacological knowledge of a S. arvensis extract for cardioprotective eff ects. The mechanism of action of S. arvensis extract as a cardioprotective can be explored further. The
